http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-260737-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 1992-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb8a8ff9c15a49d5d22f8d55d885da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743c033b5b425bbab349ceaa348d53a8 |
| publicationDate | 2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-260737-A |
| titleOfInvention | Use of alpha1-adrenergic receptor blockers in the treatment of benign prostatic hyperplasia |
| abstract | A method of treating men with benign prostatic hyperplasia (BPH) involving combination therapy of administering therapeutically effective amounts of a 5a-reductase inhibitor in combination with an a1-adrenergic receptor blocker. 5a-reductase inhibitor is selected from 17b-acyl-3-carboxy-androst-3,5-dienes, benzoylaminophenoxy butanoic acid derivatives, cinnamoylamides, fused benz(thio)amides, aromatic 1,2-diethers or thioethers, aromatic orthoacylaminophenoxy alkanoic acids, ortho-thioalkylacylaminophenoxyalkanoic acids. The structures are exemplified in Figure 1. |
| priorityDate | 1991-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1118.